Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haley K Perlow

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 17, 2023
Single-Fraction Versus Fractionated Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort StudyRoshan S Prabhu, Tobi Akinyelu, Zachary K Vaslow, et al.
Neuro-Oncology Advances|March 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomasSolmaz Sahebjam, Raju R Raval, Peter A Forsyth, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected MeningiomasHaley K Perlow, David R Raleigh, Tony J C Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2025
Pre-Operative Versus Post-Operative Fractionated Stereotactic Radiotherapy: A Single Institution Analysis of 534 Resected MetastasesHaley K Perlow, Sarah Hennings, Jared Bradshaw, et al.
Journal of Neuro-Oncology|June 3, 2025
A comparison of outcomes after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases: an international multi-center studyChris Z Wei, Regan Shanahan, David Puccio, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2026
Improved progression-free survival following dose-escalated vs. standard dose post-operative radiation therapy for high-risk meningiomas: An International Multicenter Individual Patient Level Meta-Analysis (FIRESTORM)Raj Singh, Andrew Koempel, Beck French, et al.
Neurosurgery|December 13, 2022
Stereotactic Radiosurgery for Intraventricular Metastases: A Multicenter StudyGeorgios Mantziaris, Stylianos Pikis, Zhiyuan Xu, et al.
Neuro-Oncology|May 17, 2026
Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant MeningiomasLeeor S Yefet, Alexander P Landry, C Leland Rogers, et al.
Journal of Neurosurgery|December 6, 2024
Local control and patient survival after stereotactic radiosurgery for esophageal cancer brain metastases: an international multicenter analysisOthman Bin-Alamer, Hussam Abou-Al-Shaar, Raj Singh, et al.
Neurosurgery|March 21, 2023
Local Control and Survival Outcomes After Stereotactic Radiosurgery for Brain Metastases From Gastrointestinal Primaries: An International Multicenter AnalysisRaj Singh, Greg Bowden, David Mathieu, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|September 17, 2023
Single-Fraction Versus Fractionated Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort StudyRoshan S Prabhu, Tobi Akinyelu, Zachary K Vaslow, et al.
Neuro-Oncology Advances|March 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomasSolmaz Sahebjam, Raju R Raval, Peter A Forsyth, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected MeningiomasHaley K Perlow, David R Raleigh, Tony J C Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2025
Pre-Operative Versus Post-Operative Fractionated Stereotactic Radiotherapy: A Single Institution Analysis of 534 Resected MetastasesHaley K Perlow, Sarah Hennings, Jared Bradshaw, et al.
Journal of Neuro-Oncology|June 3, 2025
A comparison of outcomes after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases: an international multi-center studyChris Z Wei, Regan Shanahan, David Puccio, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2026
Improved progression-free survival following dose-escalated vs. standard dose post-operative radiation therapy for high-risk meningiomas: An International Multicenter Individual Patient Level Meta-Analysis (FIRESTORM)Raj Singh, Andrew Koempel, Beck French, et al.
Neurosurgery|December 13, 2022
Stereotactic Radiosurgery for Intraventricular Metastases: A Multicenter StudyGeorgios Mantziaris, Stylianos Pikis, Zhiyuan Xu, et al.
Neuro-Oncology|May 17, 2026
Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant MeningiomasLeeor S Yefet, Alexander P Landry, C Leland Rogers, et al.
Journal of Neurosurgery|December 6, 2024
Local control and patient survival after stereotactic radiosurgery for esophageal cancer brain metastases: an international multicenter analysisOthman Bin-Alamer, Hussam Abou-Al-Shaar, Raj Singh, et al.
Neurosurgery|March 21, 2023
Local Control and Survival Outcomes After Stereotactic Radiosurgery for Brain Metastases From Gastrointestinal Primaries: An International Multicenter AnalysisRaj Singh, Greg Bowden, David Mathieu, et al.
Pageof 6